AbCellera Biologics(ABCL) - 2025 Q4 - Earnings Call Transcript

AbCellera Biologics (NasdaqGS:ABCL) Q4 2025 Earnings call February 24, 2026 05:00 PM ET Company ParticipantsAndrew Booth - CFOCarl Hansen - President and CEOMalcolm Hoffman - VP of BioPharma Equity ResearchSarah Noonberg - Chief Medical OfficerStephen Willey - Managing Director of HealthcareTryn Stimart - Chief Legal and Compliance OfficerConference Call ParticipantsAllison Bratzel - VP and Senior Research AnalystBrendan Smith - Director and Senior Analyst for Life Science Tools and Diagnostics/Biotechnolog ...